Single-Arm Phase II Survival Trial Design
- 263 pages
- 10 hours of reading
Focusing on advanced cancer treatment development, this book offers an in-depth overview of single-arm phase II trial designs, particularly emphasizing time-to-event endpoints. It presents a thorough examination of the most commonly utilized methodologies in this area, making it a valuable resource for researchers and practitioners involved in targeted therapies and immunotherapy.
